Mohamed S Alesawy

发表

Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies

Ahmed A. Al-karmalawy, Rogy R Ezz Eldin, Marwa A Saleh, 2022, Journal of enzyme inhibition and medicinal chemistry.

Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking

I. Eissa, Mohamed S Alesawy, M. Ibrahim, 2022, Archiv der Pharmazie.

Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.

M. Elsohly, M. Radwan, I. Eissa, 2017, Bioorganic & medicinal chemistry.

Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators

I. Eissa, Mohamed S Alesawy, M. Ibrahim, 2022, Archiv der Pharmazie.

New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation

Wagdy M. Eldehna, I. Eissa, Mohamed S Alesawy, 2022, Archiv der Pharmazie.

Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations

I. Eissa, Mohamed S Alesawy, M. Ibrahim, 2022, Archiv der Pharmazie.

Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach

I. Eissa, Abdulrahman M. Saleh, Mohamed S Alesawy, 2022, Life.

Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway

Wagdy M. Eldehna, N. El-Deeb, I. Eissa, 2022, PloS one.

Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors

I. Eissa, M. S. Taghour, Mohamed S Alesawy, 2020, Archiv der Pharmazie.

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies

Wagdy M. Eldehna, N. El-Deeb, I. Eissa, 2022, Journal of enzyme inhibition and medicinal chemistry.

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2.

Mohamed S Alesawy, A. Hassan, A. A. Al-karmalawy, 2022, Bioorganic chemistry.

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro)

M. S. Taghour, Mohamed S Alesawy, A. Metwaly, 2021, Molecules.

In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies

I. Eissa, Mohamed S Alesawy, A. Metwaly, 2021, Molecules.